Neuroendovascular Coils

Neuroendovascular Coils

Global Neuroendovascular Coils Market to Reach US$1.1 Billion by 2030

The global market for Neuroendovascular Coils estimated at US$899.1 Million in the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Bare Metal Coils, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$700.8 Million by the end of the analysis period. Growth in the Hydrogel Coated Coils segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$245.0 Million While China is Forecast to Grow at 6.8% CAGR

The Neuroendovascular Coils market in the U.S. is estimated at US$245.0 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$238.9 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Neuroendovascular Coils Market - Key Trends and Drivers Summarized

What Are Neuroendovascular Coils and How Are They Used?

Neuroendovascular coils are specialized medical devices designed for the treatment of intracranial aneurysms and other vascular malformations in the brain. These coils are introduced into the aneurysm or vascular abnormality through a catheter inserted into the blood vessels, usually via the femoral artery. Once in place, the coils are deployed to fill the aneurysm or malformation, inducing clotting and promoting the formation of a stable blood clot that helps to seal off the affected area from blood flow. This process is known as endovascular coiling and is a minimally invasive alternative to traditional open surgical procedures. Neuroendovascular coils are typically made from materials such as platinum or other biocompatible alloys, which provide both flexibility and radiopacity, allowing for precise placement under fluoroscopic guidance. The choice of coil type, including configurations such as detachable or pushable coils, depends on the specific clinical requirements and anatomical considerations of the aneurysm or vascular defect being treated.

What Are the Key Innovations in Neuroendovascular Coil Technology?

Recent advancements in neuroendovascular coil technology have significantly enhanced the effectiveness and safety of endovascular treatments. One major innovation is the development of coils with improved designs and materials, such as bioactive or drug-eluting coils, which release therapeutic agents to enhance clot formation and promote vascular healing. These advanced coils are designed to improve the long-term stability and durability of the occlusion, reducing the risk of aneurysm recanalization. The integration of advanced delivery systems and microcatheters has also improved the precision and ease of coil deployment, allowing for more accurate placement in complex anatomical regions. Additionally, innovations in coil shapes and sizes, including complex geometries and customizable configurations, have enhanced the ability to treat a wider range of aneurysm types and sizes. The ongoing research and development in coil technology continue to focus on enhancing safety profiles, reducing procedural complications, and improving patient outcomes through these technological advancements.

How Are Neuroendovascular Coils Applied Across Different Clinical Scenarios?

Neuroendovascular coils are employed in a variety of clinical scenarios to address different types of intracranial vascular issues. The primary application is in the treatment of cerebral aneurysms, where the coils are used to occlude the aneurysm and prevent rupture or bleeding. This technique is preferred for its minimally invasive nature and lower risk profile compared to open surgery. Coils are also used in the treatment of arteriovenous malformations (AVMs) and fistulas, where they help to reduce abnormal blood flow and promote normal vascular development. In some cases, coils are combined with other endovascular devices, such as stents, to provide additional support and enhance treatment efficacy. The versatility of neuroendovascular coils allows them to be used in various clinical settings, including emergency situations involving acute aneurysm rupture and elective procedures for planned aneurysm management. Their ability to address complex vascular issues with precision underscores their importance in modern neurointerventional procedures.

What Factors Are Driving the Growth of the Neuroendovascular Coils Market?

The growth in the neuroendovascular coils market is driven by several factors. Technological advancements in coil design and delivery systems are a significant driver, with innovations such as bioactive and drug-eluting coils improving treatment efficacy and patient outcomes. The increasing incidence of intracranial aneurysms and vascular malformations, coupled with the growing aging population, is contributing to higher demand for neuroendovascular treatments. The shift towards minimally invasive procedures, driven by patient preference and the benefits of reduced recovery times, is also fueling market growth. The expansion of healthcare facilities and the availability of advanced neurointerventional technologies in emerging markets are broadening access to these treatments. Additionally, ongoing research and development efforts, supported by investments from medical device companies, are leading to the introduction of new and improved products. These factors collectively drive the expansion of the neuroendovascular coils market, reflecting advancements in technology and increasing clinical applications.

Select Competitors (Total 46 Featured) -

• ASAHI INTECC USA, INC.
• BALT Group
• Boston Scientific Corporation
• Cerenovus
• Cook Medical Inc.
• Johnson & Johnson Services Inc.
• Kaneka Corporation
• Medtronic Plc
• MicroPort Scientific Corporation
• MicroVention Inc.
• NeuroVasc Technologies, Inc.
• Penumbra, Inc.
• Stryker Corporation
• Terumo Corporation;

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.